BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the company will present its pivotal Phase 3 data on suzetrigine, an investigational, oral, highly ...

The U.S. Space Force has awarded two task orders worth $733.6 million combined to SpaceX to provide Lane 1 launch services as part of the third phase of the National Security Space Launch program. The ...